Correction: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

doi:10.1186/bcr1413

Breast Cancer Research

Volume 8
Issue 3

Viewing options:

Abstract
Full text
PDF (25KB)

Associated material:

Readers' comments

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
Other articles by authors
on Google Scholar

Powles T
Paterson A
McCloskey E
Schein P
Scheffler B
Tidy A
Ashley S
Smith I
Ottestad L
Kanis J

on PubMed

Powles T
Paterson A
McCloskey E
Schein P
Scheffler B
Tidy A
Ashley S
Smith I
Ottestad L
Kanis J
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

Correction

Correction: Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Trevor Powles¹ , Alexander Paterson², Eugene McCloskey³, Phil Schein⁴, Bobbi Scheffler⁵, Alwynne Tidy⁶, Sue Ashley⁶, Ian Smith⁶, Lars Ottestad⁷ and John Kanis³

¹Parkside Oncology, London, UK

²Tom Baker Cancer Centre, Calgary, Alberta, Canada

³WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK

⁴Department of Clinical Pharmacology, University of Oxford, Oxford, UK

⁵Scheffler Group, Villanova, Pennsylvania, USA

⁶Royal Marsden Hospital, London, UK

⁷Radium Institute, Oslo, Norway

author email corresponding author email

Breast Cancer Research 2006, 8:406doi:10.1186/bcr1413


Published:	3 May 2006

First paragraph (this article has no abstract)

It has been brought to our attention that there was a typographical error in our recent article [1] published in March 2006.